Global TDS (Transdermal Delivery Systems) Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global TDS (Transdermal Delivery Systems) Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.
TDS (Transdermal Delivery Systems) report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global TDS (Transdermal Delivery Systems) market is projected to reach US$ 18990 million in 2034, increasing from US$ 15060 million in 2022, with the CAGR of 3.3% during the period of 2024 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
Global Transdermal Drug Delivery System key players include Hisamitsu, Mylan, GSK, Novartis, Teve (Actavis), etc. Global top five manufacturers hold a share over 65%. North America is the largest market, with a share over 48%, followed by Europe and Asia-
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global TDS (Transdermal Delivery Systems) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Adhex Pharma
Harro Hofliger
Tesa Labtec
Toyochem
Teva Pharmaceutical
Pfizer
IBSA Group
Teikoku Seiyaku
Endo International
Hisamitsu
Mylan
Sorrento Therapeutics
Segment by Type
Single-layer Drug-in-Adhesive
Multi-layer Drug-in-Adhesive
Others
Hospital
Clinic
Other
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the TDS (Transdermal Delivery Systems) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of TDS (Transdermal Delivery Systems), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the TDS (Transdermal Delivery Systems) industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of TDS (Transdermal Delivery Systems) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, TDS (Transdermal Delivery Systems) introduction, etc. TDS (Transdermal Delivery Systems) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of TDS (Transdermal Delivery Systems) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
TDS (Transdermal Delivery Systems) report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global TDS (Transdermal Delivery Systems) market is projected to reach US$ 18990 million in 2034, increasing from US$ 15060 million in 2022, with the CAGR of 3.3% during the period of 2024 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
Global Transdermal Drug Delivery System key players include Hisamitsu, Mylan, GSK, Novartis, Teve (Actavis), etc. Global top five manufacturers hold a share over 65%. North America is the largest market, with a share over 48%, followed by Europe and Asia-
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global TDS (Transdermal Delivery Systems) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Adhex Pharma
Harro Hofliger
Tesa Labtec
Toyochem
Teva Pharmaceutical
Pfizer
IBSA Group
Teikoku Seiyaku
Endo International
Hisamitsu
Mylan
Sorrento Therapeutics
Segment by Type
Single-layer Drug-in-Adhesive
Multi-layer Drug-in-Adhesive
Others
Segment by Application
Hospital
Clinic
Other
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the TDS (Transdermal Delivery Systems) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of TDS (Transdermal Delivery Systems), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the TDS (Transdermal Delivery Systems) industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of TDS (Transdermal Delivery Systems) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, TDS (Transdermal Delivery Systems) introduction, etc. TDS (Transdermal Delivery Systems) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of TDS (Transdermal Delivery Systems) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices